The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials-Reference-Cited by-同舟云学术

The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials

Published:2021-06 Issue: Volume:Volume 17 Page:1751-1762
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Nasser Azmi,Hull Joseph T,Liranso Tesfaye,Busse Gregory D,Melyan Zare,Childress Ann C,Lopez Frank A,Rubin Jonathan

Publisher

Informa UK Limited

Reference32 articles.

1. Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems

2. Current Investigational Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder

3. Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents

4. Assessing Treatment Outcomes in Attention-Deficit/Hyperactivity Disorder

5. Attention-deficit/hyperactivity disorder

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on ADHD disorder, diagnosis and therapeutic approach in children and adolescents;Brain-Apparatus Communication: A Journal of Bacomics;2024-09-11

2. Attention Deficit Hyperactivity Disorder in Children: A Narrative Review;Journal of Pediatric Advance Research;2024-06-10

3. The role of adrenergic neurotransmitter reuptake inhibitors in the ADHD armamentarium;Expert Opinion on Pharmacotherapy;2024-05-23

4. Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents;Expert Review of Neurotherapeutics;2024-03-19

5. Response of peer relations and social activities to treatment with viloxazine extended‐release capsules (Qelbree^®): A post hoc analysis of four randomized clinical trials of children and adolescents with attention‐deficit/hyperactivity disorder;Brain and Behavior;2023-02-27